Sunday, January 14, 2007

Tygecycline for community acquired pneumonia

In a phase 3 double blind multicenter RCT presented as a poster abstract at the IDSA 2006 annual meeting (poster 171) Tygecycline was as safe and effective as Levofloxacin in patients with community acquired pneumonia (CAP).

Tygecycline is off label at present for CAP. I expect this study will be submitted to the FDA to approve the indication.

No comments: